The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Open accessAbstract
Objective: The objective of this study was to characterise the incidence rates of herpes zoster (HZ), also known as shingles, and risk of complications across the world. Design: We systematically reviewed studies examining the incidence rates of HZ, temporal trends of HZ, the risk of complications including postherpetic neuralgia (PHN) and HZ-associated hospitalisation and mortality rates in the general population. The literature search was conducted using PubMed, EMBASE and the WHO library up to December 2013. Results: We included 130 studies conducted in 26 countries. The incidence rate of HZ ranged between 3 and 5/1000 person-years in North America, Europe and Asia-Pacific, based on studies using prospective surveillance, electronic medical record data or administrative data with medical record review. A temporal increase in the incidence of HZ was reported in the past several decades across seven countries, often occurring before the introduction of varicella vaccination programmes. The risk of developing PHN varied from 5% to more than 30%, depending on the type of study design, age distribution of study populations and definition. More than 30% of patients with PHN experienced persistent pain for more than 1 year. The risk of recurrence of HZ ranged from 1% to 6%, with long-term follow-up studies showing higher risk (5–6%). Hospitalisation rates ranged from 2 to 25/100 000 person-years, with higher rates among elderly populations. Conclusions: HZ is a significant global health burden that is expected to increase as the population ages. Future research with rigorous methods is important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
Shakespeare, T., & Officer, A. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2011.590392 · Cited by 1,792
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Factors in the Emergence of Infectious Diseases
Morse, S. S. (1995) · Emerging Infectious Diseases · doi:10.3201/eid0101.950102 · Cited by 1,271
Population-Based Study of Herpes Zoster and Its Sequelae
RAGOZZINO, M. W., MELTON, L. J., KURLAND, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 926
Recommendations for the management of herpes zoster
Dworkin, R. H., Johnson, R. W., Breuer, J., Gnann, J. W., Levin, M. J., Backonja, M., Betts, R. F., Gershon, A. A., Haanpää, M. L., McKendrick, M. W., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510206 · Cited by 869
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 734
The Incidence of Herpes Zoster
Donahue, J. G. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.15.1605 · Cited by 652
What does epidemiology tell us about risk factors for herpes zoster?
Thomas, S. L., & Hall, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00857-0 · Cited by 561
The incidence of herpes zoster in a United States administrative database
Insinga, R. P., Itzler, R. F., Pellissier, J. M., Saddier, P., & Nikas, A. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0150.x · Cited by 490
Herpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
LIESEGANG, T. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 471
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
BRISSON, M., EDMUNDS, W. J., LAW, B., GAY, N. J., WALLD, R., BROWNELL, M., ROOS, L. L., & DE SERRES, G. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801005921 · Cited by 432
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Johnson, R. W., Bouhassira, D., Kassianos, G., Leplège, A., Schmader, K. E., & Weinke, T. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-37 · Cited by 404
Risk factors for postherpetic neuralgia in patients with herpes zoster
Jung, B. F., Johnson, R. W., Griffin, D. R. J., & Dworkin, R. H. (2004) · Neurology · doi:10.1212/01.wnl.0000123261.00004.29 · Cited by 373
Coplan, P. M., Schmader, K., Nikas, A., Chan, I. S. F., Choo, P., Levin, M. J., Johnson, G., Bauer, M., Williams, H. M., Kaplan, K. M., et al. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2004.06.001 · Cited by 306
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., BREUER, J., CARRINGTON, D., MARTIN, M., & RÉMY, V. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Jumaan, A. O., Yu, O., Jackson, L. A., Bohlke, K., Galil, K., & Seward, J. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/430325 · Cited by 285
Helgason, S. (2000) · BMJ · doi:10.1136/bmj.321.7264.794 · Cited by 268
Oster, G., Harding, G., Dukes, E., Edelsberg, J., & Cleary, P. D. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2005.01.359 · Cited by 246
Similar herpes zoster incidence across Europe: results from a systematic literature review
Pinchinat, S., Cebrián-Cuenca, A. M., Bricout, H., & Johnson, R. W. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-170 · Cited by 245
Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
Tseng, H. F. (2011) · JAMA · doi:10.1001/jama.2010.1983 · Cited by 239
Opstelten, W. (2002) · Family Practice · doi:10.1093/fampra/19.5.471 · Cited by 228
Herpes Zoster Recurrences More Frequent Than Previously Reported
Yawn, B. P., Wollan, P. C., Kurland, M. J., St. Sauver, J. L., & Saddier, P. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0618 · Cited by 227
Leung, J., Harpaz, R., Molinari, N.-A., Jumaan, A., & Zhou, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq077 · Cited by 208
Yih, W. K., Brooks, D. R., Lett, S. M., Jumaan, A. O., Zhang, Z., Clements, K. M., & Seward, J. F. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-68 · Cited by 203
Langan, S. M., Smeeth, L., Margolis, D. J., & Thomas, S. L. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001420 · Cited by 203
Complications of Herpes Zoster Ophthalmicus
Womack, L. W., & Liesegang, T. J. (1983) · Archives of Ophthalmology · doi:10.1001/archopht.1983.01040010044004 · Cited by 203
Incidence of herpes zoster in patients with altered immune function
Chen, S.-Y., Suaya, J. A., Li, Q., Galindo, C. M., Misurski, D., Burstin, S., & Levin, M. J. (2014) · Infection · doi:10.1007/s15010-013-0550-8 · Cited by 198
Complications of Herpes Zoster Ophthalmicus
Harrison, E. Q. (1965) · American Journal of Ophthalmology · doi:10.1016/0002-9394(65)92826-6 · Cited by 193
Civen, R., Chaves, S. S., Jumaan, A., Wu, H., Mascola, L., Gargiullo, P., & Seward, J. F. (2009) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181a90b16 · Cited by 180
Herpes Zoster Eye Complications: Rates and Trends
Yawn, B. P., Wollan, P. C., St. Sauver, J. L., & Butterfield, L. C. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.03.014 · Cited by 176
Toyama, N., Shiraki, K., & and Members of the Society of the Miyazaki Prefecture Dermatologists (2009) · Journal of Medical Virology · doi:10.1002/jmv.21599 · Cited by 176
Gialloreti, L. E., Merito, M., Pezzotti, P., Naldi, L., Gatti, A., Beillat, M., Serradell, L., di Marzo, R., & Volpi, A. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-230 · Cited by 174
Hope-Simpson, R. E. (1975) · PubMed · Cited by 172
Incidence of herpes zoster, 1997–2002
MULLOOLY, J. P., RIEDLINGER, K., CHUN, C., WEINMANN, S., & HOUSTON, H. (2005) · Epidemiology and Infection · doi:10.1017/s095026880400281x · Cited by 165
Bouhassira, D., Chassany, O., Gaillat, J., Hanslik, T., Launay, O., Mann, C., Rabaud, C., Rogeaux, O., & Strady, C. (2012) · Pain · doi:10.1016/j.pain.2011.10.026 · Cited by 163
Bowsher, D. (1999) · European Journal of Pain · doi:10.1016/s1090-3801(99)90015-0 · Cited by 161
Loparev, V. N., Gonzalez, A., DeLeon-Carnes, M., Tipples, G. A., Fickenscher, H., Torfason, E. G., & Schmid, D. S. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8349-8358.2004 · Cited by 154
Examination of Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination
Hales, C. M., Harpaz, R., Joesoef, M. R., & Bialek, S. R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00006 · Cited by 151
de Melker, H. E., Berbers, G. A. M., Hahné, S., Rümke, H. C., van den Hof, S., de Wit, G. A., & Boot, H. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.017 · Cited by 138
Galil, K., Choo, P. W., Donahue, J. G., & Platt, R. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1209 · Cited by 137
A study of shingles and the development of postherpetic neuralgia in East London
Scott, F., Leedham-Green, M., Barrett-Muir, W. Y., Hawrami, K., Gallagher, W. J., Johnson, R. W., & Breuer, J. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10316 · Cited by 136
Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study
Drolet, M., Brisson, M., Schmader, K. E., Levin, M. J., Johnson, R. W., Oxman, M. N., Patrick, D. M., Camden, S., & Mansi, J. A. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.02.020 · Cited by 128
Postherpetic neuralgia: epidemiology, pathophysiology and management
Johnson, R. W., Wasner, G. L., Saddier, P., & Baron, R. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1581 · Cited by 127
Epidemiological Features and Costs of Herpes Zoster in Taiwan: a National Study 2000 to 2006
Jih, J., Chen, Y., Lin, M., Chen, Y., Chen, T., Huang, Y., Chen, C., Lee, D.-D., Chang, Y., Wang, W., et al. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0729 · Cited by 122
Herpes zoster in Germany: Quantifying the burden of disease
Ultsch, B., Siedler, A., Rieck, T., Reinhold, T., Krause, G., & Wichmann, O. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-173 · Cited by 122
Stein, A., Britt, H. C., Harrison, C. M., Conway, E. L., Cunningham, A. L., & MacIntyre, C. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.012 · Cited by 121
Herpes Zoster and Postherpetic Neuralgia Surveillance Using Structured Electronic Data
Klompas, M., Kulldorff, M., Vilk, Y., Bialek, S. R., & Harpaz, R. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0305 · Cited by 119
A population based study of the epidemiology of Herpes Zoster and its complications
Weitzman, D., Shavit, O., Stein, M., Cohen, R., Chodick, G., & Shalev, V. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.06.016 · Cited by 116
Wahrendorf, M., Reinhardt, J. D., & Siegrist, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071893 · Cited by 113
Increasing Incidence of Herpes Zoster among Veterans
Rimland, D., & Moanna, A. (2010) · Clinical Infectious Diseases · doi:10.1086/651078 · Cited by 113
The sequelae of herpes zoster.
Galil, K., Choo, P. W., Donahue, J. G., & Platt, R. G. (1997) · PubMed · Cited by 111
Opstelten, W., Zuithoff, N. P. A., van Essen, G. A., van Loon, A. M., van Wijck, A. J. M., Kalkman, C. J., Verheij, T. J., & Moons, K. G. M. (2007) · Pain · doi:10.1016/j.pain.2007.02.004 · Cited by 109
van Seventer, R., Sadosky, A., Lucero, M. A., & Dukes, E. M. (2006) · Age and Ageing · doi:10.1093/ageing/afj048 · Cited by 105
Natural history of pain following herpes zoster
Thyregod, H. G. H., Rowbotham, M. C., Peters, M., Possehn, J., Berro, M., & Petersen, K. L. (2006) · Pain · doi:10.1016/j.pain.2006.09.021 · Cited by 102
Incidence of Herpes Zoster Ophthalmicus: Results from the Pacific Ocular Inflammation Study
Borkar, D. S., Tham, V. M., Esterberg, E. J., Ray, K. J., Vinoya, A. C., Parker, J. V., Uchida, A., & Acharya, N. R. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.007 · Cited by 101
Yawn, B. P., Wollan, P. C., & Sauver, J. L. S. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr206 · Cited by 92
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan
Lin, Y.-H., Huang, L., Chang, I., Tsai, F., Lu, C., Shao, P., & Chang, L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.029 · Cited by 89
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany
Ultsch, B., Köster, I., Reinhold, T., Siedler, A., Krause, G., Icks, A., Schübert, I., & Wichmann, O. (2012) · The European Journal of Health Economics · doi:10.1007/s10198-012-0452-1 · Cited by 89
The incidence of shingles and its implications for vaccination policy
Chapman, R. S., Cross, K. W., & Fleming, D. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00034-3 · Cited by 86
Ghaznawi, N., Virdi, A. S., Dayan, A. C., Hammersmith, K. M., Rapuano, C. J., Laibson, P. R., & Cohen, E. J. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.04.002 · Cited by 86
Tseng, H. F., Chi, M., Smith, N., Marcy, S. M., Sy, L. S., & Jacobsen, S. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis334 · Cited by 84
Lukas, K., Edte, A., & Bertrand, I. (2011) · Journal of Public Health · doi:10.1007/s10389-011-0481-8 · Cited by 83
Clinical and psychosocial correlates of post‐herpetic neuralgia
Volpi, A., Gatti, A., Pica, F., Bellino, S., Marsella, L., & Sabato, A. F. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21254 · Cited by 79
Tanuseputro, P., Zagorski, B., Chan, K. J., & Kwong, J. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.024 · Cited by 76
Herpes zoster: Burden of disease in France
Chiappe, S. G., Sarazin, M., Turbelin, C., Lasserre, A., Pelat, C., Bonmarin, I., Chosidow, O., Blanchon, T., & Hanslik, T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.074 · Cited by 76
Secular trends in the epidemiology of shingles in Alberta
RUSSELL, M. L., Schopflocher, D., Svenson, L. W., & VIRANI, S. N. (2007) · Epidemiology and Infection · doi:10.1017/s0950268807007893 · Cited by 76
the VZV Pain Study Group, Parruti, G., Tontodonati, M., Rebuzzi, C., Polilli, E., Sozio, F., Consorte, A., Agostinone, A., Masi, F. D., Congedo, G., et al. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-58 · Cited by 75
Varicella and Herpes Zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004
Pérez‐Farinós, N., Ordobás, M., García‐Fernández, C., Comas, L. G., Llabrés, S. C., Rodero, I., Gutiérrez-Rodríguez, A., García-Gutiérrez, J., & Ramírez, R. (2007) · BMC Infectious Diseases · doi:10.1186/1471-2334-7-59 · Cited by 75
Katz, J., McDermott, M., Cooper, E. M., Walther, R. R., Sweeney, E. W., & Dworkin, R. H. (2005) · Journal of Pain · doi:10.1016/j.jpain.2005.07.006 · Cited by 74
Chao, D., Chien, Y.-Z., Yeh, Y., Hsu, P.-S., & Lian, I. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001786 · Cited by 73
A prognostic score for postherpetic neuralgia in ambulatory patients
Meister, W., Neiß, A., Gross, G., Doerr, H. W., Höbel, W., Malin, J.-P., von Essen, J., Reimann, B.-Y., Witke, C., & Wutzler, P. (1998) · Infection · doi:10.1007/bf02770836 · Cited by 70
The health and economic burden of chickenpox and herpes zoster in Belgium
Bilcke, J., Ogunjimi, B., Marais, C., Smet, F. D., Callens, M. G., Callaert, K., Kerschaver, E. V., Ramet, J., Damme, P. V., & Beutels, P. (2012) · Epidemiology and Infection · doi:10.1017/s0950268811002640 · Cited by 69
Shingles in Alberta: Before and after publicly funded varicella vaccination
Russell, M. L., Dover, D. C., Simmonds, K., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.018 · Cited by 66
Coen, P. G., Scott, F., Leedham-Green, M., Nia, T., Jamil, A., Johnson, R. W., & Breuer, J. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.11.002 · Cited by 65
Studahl, M., Petzold, M., & Cassel, T. N. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-586 · Cited by 61
The clinical course of herpes zoster: A prospective study in primary care
Helgason, S., Sigurdsson, J. A., & Gudmundsson, S. R. (1996) · European Journal of General Practice · doi:10.3109/13814789609161651 · Cited by 60
Different vaccination strategies in Spain and its impact on severe varicella and zoster
Gil-Prieto, R., Walter, S., González-Escalada, A., García‐García, L., Marín‐García, P., & de Miguel, Á. G. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.008 · Cited by 55
Cuenca, A. M. C., Díez‐Domingo, J., San-Martín-Rodríguez, M., Puig‐Barberà, J., & Navarro-Pérez, J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-302 · Cited by 54
Epidemiology and costs of herpes zoster: Background data to estimate the impact of vaccination
Legami, V. D., Gianino, M. M., Atti, M. L. C. D., Massari, M., Migliardi, A., Tomba, G. S., & Zotti, C. M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.049 · Cited by 52
Weinke, T., Edte, A., Schmitt, S., & Lukas, K. (2010) · Journal of Public Health · doi:10.1007/s10389-010-0323-0 · Cited by 51
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)
Talamante, N. M., Díez‐Domingo, J., Martínez-Úbeda, S., Puig‐Barberà, J., Alemán-Sánchez, S., & Pérez–Breva, L. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-463 · Cited by 49
Disease burden of herpes zoster in Korea
Choi, W. S., Noh, J. Y., Huh, J. Y., Jo, Y. M., Lee, J., Song, J. Y., Kim, W. J., & Cheong, H. J. (2010) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.01.003 · Cited by 48
Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998–2004)
de Miguel, Á. G., Gil-Prieto, R., Alvaro, A., Martín, M. S., & González, A. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-55 · Cited by 46
Nelson, M. R., Britt, H. C., & Harrison, C. M. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03818.x · Cited by 40
JARDINE, A., Conaty, S. J., & Vally, H. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810001949 · Cited by 40
Hospitalizations to Treat Herpes Zoster in Older Adults: Causes and Validated Rates
Jackson, L. A., Reynolds, M. A., & Harpaz, R. (2008) · Clinical Infectious Diseases · doi:10.1086/591132 · Cited by 38
Cho, S. I., Lee, C. H., Park, G., Park, C. W., & Kim, H. O. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.10.006 · Cited by 34
Natural history of herpes zoster: Late follow-up of 3.9 years (n = 43) and 7.7 years (n = 10)
Reda, H. M., Greene, K. A., Rice, F. L., Rowbotham, M. C., & Petersen, K. L. (2013) · Pain · doi:10.1016/j.pain.2013.04.015 · Cited by 34
Mick, G., Gallais, J.-L., Simón, F., Pinchinat, S., Bloch, K., Beillat, M., Serradell, L., & Derrough, T. (2010) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2010.06.166 · Cited by 34
Clinical Correlates of Prolonged Pain in Japanese Patients with Acute Herpes Zoster
Kurokawa, I., KUMANO, K., Murakawa, K., & The Hyogo Prefectual PHN Study Group (2002) · Journal of International Medical Research · doi:10.1177/147323000203000109 · Cited by 32
Cuenca, A. M. C., Díez‐Domingo, J., Rodríguez, M. S.-M., Puig‐Barberà, J., & Navarro-Pérez, J. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-33 · Cited by 32
Watson, C. P. N., & Oaklander, A. L. (2002) · Pain Practice · doi:10.1046/j.1533-2500.2002.02039.x · Cited by 32
Esteban-Vasallo, M. D., Gil-Prieto, R., Domínguez‐Berjón, M. F., Astray‐Mochales, J., & de Miguel, Á. G. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.035 · Cited by 29
McKendrick, M. W., Ogan, P., & Care, C. C. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.008 · Cited by 23
Mahamud, A. S., Marin, M., Nickell, S. P., Shoemaker, T. R., Zhang, J. X., & Bialek, S. R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis575 · Cited by 23
Predictive Factors for Postherpetic Neuralgia Using Ordered Logistic Regression Analysis
Kanbayashi, Y., Onishi, K., Fukazawa, K., Okamoto, K., Ueno, H., Takagi, T., & Hosokawa, T. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318243ee01 · Cited by 22
de Oliveira, C. A., de Castro, A. P. C. R., & Miyahira, S. A. (2016) · Revista Dor · doi:10.5935/1806-0013.20160048 · Cited by 7
Cited by
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity?
Duggal, N. A., Niemiro, G., Harridge, S. D. R., Simpson, R. J., & Lord, J. M. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0177-9 · Cited by 436
Vaccination in the elderly: The challenge of immune changes with aging
Ciabattini, A., Nardini, C., Santoro, F., Garagnani, P., Franceschi, C., & Medaglini, D. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.010 · Cited by 411
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Metadata
- Authors
- Kawai, K., Gebremeskel, B. G., & Acosta, C. J.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2014-06
- Volume
- 4
- Issue
- 6
- Pages
- e004833
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2040947756
- Cited by
- 938
- References
- 100
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.